SCHEMBL2992154

SCHEMBL2992154

CNC(=N)NN

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL10976926 0.97
Hydrochloric Acid SCHEMBL11632396 0.97
Iodide SCHEMBL10971627 0.97
Bicarbonate SCHEMBL9227212 0.88 CYP1A2 (0.33)
SCHEMBL215025 0.76
SCHEMBL35024 0.76
SCHEMBL20431349 0.73
SCHEMBL16597136 0.73
Bromide SCHEMBL11720833 0.72
Hydrochloric Acid SCHEMBL2278008 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 58 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0210291-A1 Platinum complexes of antitumor agents AMERICAN CYANAMID COMPANY (US) 1987-02-04 EP claimed
US-4544759-A Platinum complexes of antitumor agents AMERICAN CYANAMID COMPANY (US) 1985-10-01 US claimed
CN-119522110-A Novel linker compounds and ligand-drug conjugates thereof 特里奥尔株式会社 2025-02-25 CN disclosed
CN-119451701-A Compounds comprising self-destructing groups and ligand-drug conjugates comprising the same 特里奥尔株式会社 2025-02-14 CN disclosed
EP-3995489-A2 DISULFIDE COMPOUNDS FOR DELIVERY OF PHARMACEUTICAL AGENTS Tufts University (US) 2022-05-11 EP disclosed
US-10774171-B2 Energetic compounds and compositions TECHNOLOGY INNOVATION MOMENTUM FUND (ISRAEL) LIMITED PARTNERSHIP (IL) 2020-09-15 US disclosed
US-20200102269-A1 O-ALKYL-BENZYLIDENEGUANIDINE DERIVATIVES AND THERAPEUTIC USE FOR THE TREATMENT OF DISORDERS ASSOCIATED WITH AN ACCUMULATION OF MISFOLDED PROTEINS INFLECTIS BIOSCIENCE (FR) 2020-04-02 US disclosed
US-10544103-B2 5-HT2 antagonists ANAMAR AB (SE) 2020-01-28 US disclosed
US-20190092895-A1 ENERGETIC COMPOUNDS AND COMPOSITIONS TECHNOLOGY INNOVATION MOMENTUM FUND (ISRAEL) LIMITED PARTNERSHIP (IL) 2019-03-28 US disclosed
US-10077241-B2 Tetrahydro-benzoimidazolyl modulators of TGR5 JANSEN PHARMACEUTICA NV (BE) 2018-09-18 US disclosed
US-20170226270-A1 ENERGETIC COMPOUNDS AND COMPOSITIONS TECHNOLOGY INNOVATION MOMENTUM FUND (ISRAEL) LIMITED PARTNERSHIP (IL) 2017-08-10 US disclosed
US-4983604-A Aminoguanidine derivatives THE ROCKEFELLER UNIVERSITY (US) 1991-01-08 US disclosed
US-4978684-A ADMINISTERING AMINOGUANIDINE DERIVATIVE THE ROCKEFELLER UNIVERSITY (US) 1990-12-18 US disclosed
US-4933268-A OXONOL DYE HAVING PYRAZOLONE NUCLEUS FUJI PHOTO FILM CO., LTD. (JP) 1990-06-12 US disclosed
US-4908446-A Inhibitors of nonenzymatic cross-linking THE ROCKEFELLER UNIVERSITY (US) 1990-03-13 US disclosed
EP-0327919-A2 Method and agents for preventing staining of teeth THE ROCKEFELLER UNIVERSITY (US) 1989-08-16 EP disclosed
EP-0316852-A2 Inhibitors of nonenzymatic cross-linking THE ROCKEFELLER UNIVERSITY (US) 1989-05-24 EP disclosed
EP-0316013-A2 Silver halide photographic material having at least one dyed hydrophilic colloid layer Fuji Photo Film Co., Ltd. (JP) 1989-05-17 EP disclosed
EP-0210291-A1 Platinum complexes of antitumor agents AMERICAN CYANAMID COMPANY (US) 1987-02-04 EP disclosed
US-4544759-A Platinum complexes of antitumor agents AMERICAN CYANAMID COMPANY (US) 1985-10-01 US disclosed